久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

EU to overhaul strategy after J&J jab questions

By ANGUS McNEICE in London | China Daily Global | Updated: 2021-04-15 09:22
Share
Share - WeChat
Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken Oct 31, 2020. [Photo/Agencies]

Unexpected pause in use could push back continent's vaccination timeline

The European Union appears set to shift its vaccine strategy in favor of shots that use messenger RNA technology, such as those from Pfizer and Moderna, and decrease its reliance on so-called viral vector vaccines, which include those from Johnson& Johnson and AstraZeneca.

Viral vector vaccine uses modified versions of a different virus to provoke an immune response.

"We need to focus now on technologies that have proven their worth; mRNA vaccines are a clear case in point," European Commission President Ursula von der Leyen said during a news conference on Wednesday afternoon.

Her comments came after Europe's vaccine program was thrown into disarray for a second time due to safety concerns over a viral vector treatment.

The EU was poised to begin the distribution of 55 million doses of the Johnson& Johnson jab, before United States regulators recommended a pause in use of the vaccine following six reports of a rare and serious form of blood clotting among those treated.

Prior to this, a number of EU member states had paused the distribution of the AstraZeneca jab following a small number of reports of blood clots in vaccinated people.

The Johnson & Johnson jab was due to play a key role in the EU's drive to reach 75 percent vaccine coverage among adults by the end of the summer. Member states are now scrambling to prevent further delays to an already sluggish vaccine roll out, which remains well behind those of the US and the United Kingdom.

"If the EU can't use the Johnson&Johnson vaccine indefinitely, it could push the timeline for vaccinating 75 percent of the population back into December," London-based science analytics company Airfinity told Reuters on Wednesday.

More than 100 million EU citizens have received at least one novel coronavirus vaccine so far, Von der Leyen said on Wednesday, representing about a fifth of the population. In comparison, more than a third of the population of the US has received a shot, and almost half of the UK population has been at least partially vaccinated.

Von der Leyen confirmed that Pfizer would bring forward a 50-million-dose order that was initially scheduled for the winter, which will make up for some of the shortfall from the ill-fated Johnson & Johnson rollout. The Pfizer vaccine requires two doses per person, while the Johnson &Johnson vaccine requires one.

The EU is now due to receive a total 250 million shots from Pfizer in the second quarter of this year.

Italian newspaper La Stampa quoted an unnamed source in Italy's health ministry on Wednesday saying the EU Commission may not renew its contracts with producers of viral vector vaccines.

Media outlets in Denmark are reporting that the country will entirely halt the use of the AstraZeneca vaccine, and has also put on hold the use of the Johnson & Johnson jab. South Africa has also confirmed a pause in the distribution of the Johnson& Johnson jab.

Ian Douglas, who is a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine, said investigations into the vaccines are necessary in order to first establish if there is a causal link between the shots and clotting, and subsequently to identify any risk factors among certain populations, to minimize any adverse reactions.

But he also said it is "vital to stress" that cases of clotting are "incredibly rare".

"In this instance, around a one-in-a-million-chance based on what we know to date about the Johnson &Johnson vaccine," Douglas said.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 亚洲视频免费播放 | 久久久久久亚洲精品中文字幕 | 国产精品手机在线亚洲 | 久在草在线 | 久久99精品视香蕉蕉 | 国产欧美日韩不卡一区二区三区 | 手机毛片免费看 | 国产一区二区在线观看视频 | 国产玖玖玖精品视频 | 免费视频成人国产精品网站 | 免费特黄视频 | 国产伦一区二区三区四区久久 | 久草在线资源视频 | 久色网址 | 8050网午夜一级毛片免费不卡 | 国产亚洲精品久久麻豆 | 国产亚洲精彩视频 | 视频在线色 | 亚洲欧美视频二区 | 一级片高清| 青青自拍| 高清国产一级精品毛片基地 | 岛国伊人| 性感美女视频黄.免费网站 性高湖久久久久久久久 | 日本加勒比在线 | 久草在线新首页 | 国内高清久久久久久久久 | 香港经典a毛片免费观看看 香港经典a毛片免费观看爽爽影院 | 亲子乱子伦xxxxxinin | 国产亚洲欧美在线播放网站 | 欧美成人免费全部观看天天性色 | 99在线国产 | 日本欧美久久久久免费播放网 | 日产国产精品久久久久久 | 亚洲 欧美 91 | 亚洲一区二区三区国产精品 | 91精品啪在线看国产网站 | 亚洲图片在线视频 | 新版天堂中文资源官网 | 欧美一级毛片欧美大尺度一级毛片 | 亚洲视频国产 |